News Center

Home page

Peak Report

News reports

Peak Pharmaceutical has another postdoctoral entrance to open the topic.

Release time:

2023-06-25

On the afternoon of June 15, the post-doctoral research station of Jianfeng Pharmaceutical held a review meeting for Dr. Wu Zhuo from Donghua University.

Dr. Wu Zhuo's main research directions are research and development of new cardiovascular and cerebrovascular drugs, total synthesis of natural products, and organic synthesis technology. He has published more than ten papers in internationally renowned academic journals such as Eur. J. Med. Chem, and has won many excellent papers awards at the annual meeting of microbiology and biochemical drugs of Shanghai Pharmaceutical Association. Dr. Wu Zhuo's research project in the post-doctoral research station of Jianfeng Pharmaceutical is entitled "Design, synthesis and anti-tumor mechanism of oxindole compounds based on p53 target". At the opening review meeting, he elaborated on the background of the research project, the significance of the topic, the key problems to be solved, the solution plan, the main technical difficulties and innovation points, the work schedule and the budget, and accepted the questions and comments of the expert group.

The expert group of the opening review meeting is headed by Professor Chen Zhilong of Donghua University. Its members include Professor Wu Fanhong of Shanghai University of Applied Technology, Professor Fang Weijie of Zhejiang University's School of Pharmacy, Professor Jin Zhunian of Jinhua Vocational and Technical College of Pharmacy and Dr. Zhang Qiang, chief scientist of Jianfeng Pharmaceutical. Among them, Professor Chen Zhilong and Dr. Zhang Qiang will serve as Dr. Wu Zhuo's on-site co-site mentors respectively. Leaders of Jinhua Human Resources and Social Security Bureau, Science and Technology Bureau, Jinhua Development Zone Organization Human Resources and Social Security Bureau and other relevant departments, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, Huang Jinlong, deputy general manager of the group company and general manager of the pharmaceutical company, also attended the meeting. Jiang Xiaomeng, the host of the

opening review meeting, expressed his heartfelt thanks to all the leading experts for their arrival, and briefly introduced the development process of Jianfeng Pharmaceutical, and affirmed the work achievements of the postdoctoral workstation that has been rated as an excellent workstation for many years. He believes that Dr. Wu Zhuo's inbound research project has scientific significance and application value, and expects the research project to achieve the desired results. Huang Jinlong said that the P53 target is an important anti-cancer target that is currently being focused on at home and abroad. It is believed that with the continuous deepening of the research on this target, it will play a positive role in promoting the research and application of anti-cancer drugs. The company will fully support the research of this subject, provide all-round protection in terms of talents, equipment, funds, etc., and require Dr. Zhang Qiang to spend more energy to guide and participate in project research, I look forward to the early results and the early completion of the project.

After discussion, the expert group believed that Dr. Wu Zhuo's research project was selected appropriately, based on sufficient basis, with clear objectives and requirements, and the design scheme was feasible. He himself was capable of undertaking the research of the subject, and the relevant funds and schedule were reasonable. He agreed to open the topic. (Zhu Ningyan)

More information

2022 China's Top 100 Building Materials Enterprises 2022 China's Top 100 Cement Clinker Production Capacity Peak even on two authoritative lists

In March, the authoritative organization of the cement industry successively released two series of lists of China's top 500 building materials enterprises in 2022 and China's top 100 cement clinker production capacity in 2022. Jianfeng Group ranked among the "top 100" in the two lists ". The list of China's top 500 building materials enterprises was officially released in early March. This series of lists was selected by the China Building Materials Enterprise Management Association. Through more than 20 years of comprehensive data research on China's building materials industry, referring to international practices, the rankings are based on the company's annual operating income., Cement products, building ceramics, waterproof materials, aluminum-plastic profiles, coatings, glass, building materials equipment manufacturing and other sub-industries related to building materials. Jianfeng Group ranks 96th among the companies on the list and 27th among the cement manufacturers on the list. On March 16, the awarding ceremony of 2022 China's top 100 cement clinker production capacity list was held in Hangzhou. This series of lists is released by China Cement Network, an authoritative organization in China's cement industry. The ranking is based on the total production capacity (excluding the production capacity of other kiln types and grinding stations) of new dry clinker production lines completed and put into operation by Chinese cement enterprises in China as of December 31, 2022. The data statistics are calculated based on the design production capacity and 310 days of annual operation. Jianfeng Group ranked 53rd with an annual design capacity of 3.627 million tons. (this newspaper reporter)

2023

03-21

Company sends off retired employees

On the morning of February 22, the trade union of the group company held a simple and warm farewell party for retired employees in 2021-2022. More than 50 retired employees gathered together to discuss and exchange with Jiang Xiaomeng and other group leaders.

2023

03-04

On the first day of the new year, group leaders went to the grassroots level.

On January 29, the first day of work after the Spring Festival holiday, the leaders of the group company made a video connection to subordinate enterprises stationed abroad, and separately visited the gold enterprises to learn about the resumption of work and put forward requirements for the implementation of the work plan for the new year.

2023

02-17

Group Companies Commend 2022 Advanced

On the morning of January 18, the group company held the 2022 annual summary commendation meeting to review the work of the previous year, make arrangements for the work in 2023, sign the 2023 economic responsibility system with various professional companies and directly affiliated enterprises, and solemnly commend the 2022 advanced collectives and individuals.

2023

01-29

Jiang Xiaomeng re-elected chairman of the Municipal Federation of Industry and Commerce

On December 24, 2022, the Jinhua Federation of Industry and Commerce (General Chamber of Commerce) held the seventh member representative meeting. Jiang Xiaomeng, secretary of the party committee and chairman of the group company, was re-elected as the chairman of the Municipal Federation of Industry and Commerce at this meeting.

2023

01-12

Peak Pharmaceutical Donates Epidemic Prevention Materials

Since the optimization and adjustment of the new crown infection epidemic management policy, there has been an explosive growth of infected people in the country, and the pressure on the supply of related materials has increased sharply. Before and after New Year's Day, the company has twice organized epidemic prevention materials, through the Jinhua City Charity Federation, Jinhua City Economic and Technological Development Zone Charity Federation targeted donations, a total value of more than 200,000 yuan.

2023

01-12

< 1 2 3 4...61 > 跳转到页